documento - Plataforma de formación de SEPAR

C. Terapias psicológicas en la deshabituación
tabáquica. Psiquis, 2001; 22(6): 251-
263.
19 Goldstein MG. Bupropion sustained release
and smoking cessation. J Clin
Psychiatry. 1998; 59 (Suppl. 4): 66-72.
20 Pontieri FE, Tanda G, Orzi F. Effects of
nicotine on the nucleus accumbens and
similarity to those of addictive drugs.
Nature. 1996; 382: 255-257.
21 Edwards KL, Austin MA, Jarvik GP.
Evidence for genetic influences on smoking
in adult women twins. Clin Genet. 1995; 47:
236-244.
22 Nakajima M, Yamamoto T, Nunoya K-I,
Yokoi T, Nagashima K, Inoue K, Funae Y,
Shimada N, Kamataki T and Kuroiwa Y. Role
of human CYP2A6 in C-oxidation of nicotine.
Drug Metab Dispos. 1996; 24: 1212-1217.
23 Schultz W, Dayan P, Montagne PR. A
neural substrate of prediction and reward.
Science. 1997; 275: 1593-1599.
24 Seeman P, Van Tol HH. Dopamine receptor
pharmacology. Trends Pharmacol Sci.
1994; 15: 264-270.
25 Rodríguez de Fonseca F, Navarro M. Role
of the limbic system independence on
drugs. Ann Med. 1988; 30: 397-405.
26 Fowler JS, Volkow ND, Wang GJ, Pappas
N, Logan J, MacGregor R, Alexoff D, Shea C,
Wolf AP, Warner D, Zezulkova I, Cilento R.
Inhibition of Monoamine Oxidase B in the
Brains of Smokers. Nature 1996; 379: 733-
736.
27 Kulkarni SK. Clonidine and abstinence
syndrome. Drugs Today. 1988; 24: 411-419.
28 Grenhoff J, Svensson TH. Pharmacology
of nicotine. Br J Addict. 1989; 84: 477-492.
29 Matta SG, Singh J, Sharp BM.
Catecholamines mediate nicotine-induced
adrenocorticotropin secretion via alphaadrenergic
receptores. Endocrinology.
1990; 127: 1646-1655.
30 Westfall TC, Mereu G, Vickery L, Pery H,
Naes L, Yoon KWP. Regulation of nicotine of
midbrain dopamine neurons. In: Nicotinic
receptores in the CNS: Their role in synaptic
transmission. Nordberg A, Fuxe K,
Holmstedt B y Sundwall A (eds.). Elsevier,
Prog Brain Res. 1989; 79: 73-185.
31 Wonnacott S. Brain nicotine binding
sites. Hum Toxicol. 1987; 6: 343-353.
32 McGehee DS, Role LW. Physiological
diversity of nicotinic acetylcholine receptores
expressed by vertebrate neurons. Annu
Rev Physiol. 1995; 57: 521-546.
33 Marks MJ, Burch JB, Collins AC. Effects of
chronic nicotine infusion on tolerance development
and nicotinic receptores. J
Pharmacol Exp Ther. 1983; 226: 817-825.
34 Benwell ME, Balfour DJ, Anderson JM.
Evidence that tobacco smoking increases
the density of 3H nicotine binding sites in
human brain. J Neurochem. 1988; 50:
1243-1247.
35 Ismail Z, El-Guebaly N. Nicotine and endogenous
opioids: Toward specific pharmacotherapy.
Can J Psychiatry. 1998; 43: 37-42.
36 Krisnam.-Sarin S, Rosen MI, O´Malley
SS. Naloxone challenge in smokers. Arch
Gen Psychiatry. 1999; 56: 663-668.
37 Pierce RC, Kalivas PW. A circuitry model
of the expression of behavioral sensitization
to amphetamine-like psycostimulants. Brain
Res Rev. 1997; 25: 192-216.
38 Shoaib M, Stolerman IP. MK-801 attenuates
behavioural adaptation to chronic
nicotine administration in rats. Br J Pharm.
1992; 105: 514-515.
39 American Psychiatric Association.
Cursos de formación continuada
Diagnostic and statistical manual of mental
Disorders - Fourth edition (DSM-IV). American
Psychiatric Association. Washington
DC. 1994.
40 Kaplan HI, Sandock BJ. Trastornos relacionados
con sustancias. En Sinopsis de
Psiquiatría. Ciencias de la conducta. Psiquiatría
clínica. 8ª edición. España junio 1999.
426-96.
41 Rose JE. Nicotine addiction and treatment.
Ann Rev Med. 1996; 47: 493-507.
42 Sherwood N. Effects of nicotine on
human psychomotor performance. Hum
Psychopharm. 1993; 8: 155-184.
43 Clarke PBS. Nicotine dependencemechanisms
and therapeutic strategies.
Biochem Soc Symp. 1994; 59: 83-95.
44 Lee EW, D`Alonzo GE. Cigarrette smoking,
nicotine addiction, and its pharmacologic
treatment. Arch Intern Med. 1993; 153:
34-38.
45 Henningfield JE. Nicotine medications for
smoking cessation. N Engl J Med. 1995;
333: 1196-1203.
46 Marín D, González J. El tabaquismo
como drogodependencia. En Alonso JM,
Banegas JR, Begoña E, Cruz JM, Estapé J,
García JC y cols. Libro blanco sobre el
tabaquismo en España. Ed Glosa 1998. 89-
109.
47 Neal L, Benowitz MD. Tabaquismo de
cigarrillos y adicción a la nicotina. En Fiore
MC, MPH MD. Clínicas médicas de Norteamérica,
Tabaquismo de cigarrillos: Guía Clínica
para la valoración y el tratamiento. De
Interamericana, 1992.
48 Hughes JR, Higgins ST, Bickel WK.
Nicotine withdrawal versus other drug withdrawal
syndromes: similarities and dissimilarities.
Addiction 1994; 89: 1461-1470.
49 Pickworth WB, Herning IR, Henningfield
El tabaquismo un problema de salud pública
JE. Spontaneous E.E.G changes during
tobacco abstinence and nicotine substitution
in human volunteers. J Pharmacol Exp Ther.
1989; 251:976-82.
50 Kato S, Wakasa Y, Yanagita T.
Relationship between minimum reinforcing
doses and injection speed in cocaine and
phenobarbital self administration in crabeating
monkeys. Pharmacol Biochem Behav.
1987; 28:407-10.
51 Jiménez C, González JM, Escudero C,
García A, Roca J, Solano S, Pérez Trullén A.
El consumo de tabaco como un proceso. En:
Jiménez CA. Manuales SEPAR: Tabaquismo,
Volumen 1. Ed Aula Médica, Madrid. 1995.
58-63.
52 Gritz ER. Patterns of puffing cigarette
smokers. In: Krasaegor NA (ed.). Self administration
of abused substances: Methods
for study (NIDA Research Monograph 20).
Rockville. Maryland. National Institute en
Drug Abuse, pp. 22135. 1978.
53 Katz J, Golberg S. Second order for
understanding reinforcing effects of abused
drugs. In: Mello NK (ed.). Advances in substance
Abuse. Vol. 3 Greenwich.
54 Fagerström KO. Measuring degree of
physical dependence to tobacco smoking
with reference to individualization of treatment.
Addict Behav. 1978; 3: 235-241.
55 Etter JF, Le Houezec J, Perneger TV. A
self-administered questionnaire to measure
dependence on cigarettes: The cigarette
dependence scale.
Neuropsychopharmacology. 2003; 28 (2):
359-370.
56 Tonnensen P, Fryd V, Hansell M, Helsted
J, Gunnersen AB et al. Two and four mg
nicotine chewing gum and group counselling
in smoking cessation: an open, randomized
controlled trial with a 22 month follow-up.
Addict Behav. 1988; 13: 17-27.
57 Pomerleau CS, Pomerleau OF, Majchzak